Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00301990
Title Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

renal cell carcinoma

Therapies

Aldesleukin + Bevacizumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Jonsson Comprehensive Cancer Center at UCLA Recruiting Los Angeles California 90095-1781 United States Details
Cardinal Bernardin Cancer Center at Loyola University Medical Center Recruiting Maywood Illinois 60153 United States Details
Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis Indiana 46202-5289 United States Details
Beth Israel Deaconess Medical Center Recruiting Boston Massachusetts 02215 United States Details
Barbara Ann Karmanos Cancer Institute Recruiting Detroit Michigan 48201-1379 United States Details
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Recruiting Lebanon New Hampshire 03756-0002 United States Details
Our Lady of Mercy Medical Center Comprehensive Cancer Center Recruiting Bronx New York 10466 United States Details
Providence Cancer Center at Providence Portland Medical Center Recruiting Portland Oregon 97213-2967 United States Details
UPMC Cancer Centers Recruiting Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt-Ingram Cancer Center Recruiting Nashville Tennessee 37232-6838 United States Details
University of Virginia Cancer Center Recruiting Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field